Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis
Clinical trial NCT00388505 · COMPLETED
Trial details
- NCT number
- NCT00388505
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2009-03-01
- Enrollment
- 517
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.